BioLife Solutions Inc.

NASDAQ: BLFS · Real-Time Price · USD
24.48
0.14 (0.58%)
At close: Aug 18, 2025, 3:59 PM
24.50
0.08%
After-hours: Aug 18, 2025, 04:10 PM EDT

BioLife Solutions Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
82.25M 143.27M 76.24M 119.16M
Cost of Revenue
28.58M 96.52M 107.94M 81.41M
Gross Profit
53.67M 46.75M 53.82M 37.75M
Operating Income
-7.13M -70.83M -5.92M -35.16M
Interest Income
n/a n/a 687K 485K
Pretax Income
-11.43M -66.26M -4.85M -29.03M
Net Income
-20.18M -66.43M -139.81M -8.91M
Selling & General & Admin
50.15M 80.31M 69.24M 48.09M
Research & Development
7.91M 18.8M 14.8M 11.82M
Other Expenses
2.74M 18.47M 9.7M 8.2M
Operating Expenses
60.8M 117.58M 93.73M 68.11M
Interest Expense
719K 1.81M 687K 485K
Selling & Marketing Expenses
9.61M 12.71M 11.67M 14M
Cost & Expenses
89.38M 214.1M 82.16M 154.32M
Income Tax Expense
-38K 169K -5.24M -20.12M
Shares Outstanding (Basic)
46.07M 43.72M 42.48M 38.5M
Shares Outstanding (Diluted)
46.07M 43.72M 42.48M 38.5M
EPS (Basic)
-0.44 -1.52 -3.29 -0.23
EPS (Diluted)
-0.44 -1.52 -3.29 -0.23
EBITDA
1.53M -45.24M -124.18M -16.65M
EBIT
-7.13M -57.53M -144.14M -29.52M
Depreciation & Amortization
8.66M 12.29M 19.96M 12.87M